Definium Therapeutics, Inc. (DFTX)

17.62 +0.17 (+0.97%) USD  |  NASDAQ  |  Feb 25, 16:00
17.23 -0.39 (-2.21%) After-Hours: 06:55
More

Definium Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for DFTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Pulse Biosciences, Inc. Upgrade
RxSight, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Nutriband, Inc. Upgrade